White Papers

COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

Integrated Services: Partnerships For Success

Efficiency, speed-to-market, and access to unique expertise are among the key benefits of partnering...

Enhancing Bioavailability When Developing Oral Solid Formulations

Poor bioavailability, often caused by low solubility, is a challenge facing many NCEs. In this paper...

Patient Centricity: A compassionate Approach That Puts Patients At The Forefront Of Our Mission

Embracing a patient-focused ideology represents a massive change for a CDMO. In our new white paper,...

Designing In Vitro Dissolution

Important lessons learnt from working with formulators to develop optimal in vitro dissolution test...

Myths about Biocatalysis

Myths about Biocatalysis every manufacturer should ignore

The Unique Needs Of The HPAPI Market . Are You Prepared?

The Unique Needs Of The HPAPI Market. Are You Prepared?